Why is malaria missed in non-endemic countries?
As illustrated by the case described here, the symptoms of malaria are non-specific and can easily be mistaken for a viral illness such as influenza, unless clinicians think to ask patients whether they have travelled abroad.
A retrospective observational study of 191 deaths due to malaria in the United Kingdom from 1987 to 2006 found that the case fatality was inversely related to incidence, suggesting that cases were more easily missed by clinicians unaccustomed to seeing this disease. 4 A retrospective series of 39 cases of malaria diagnosed in Sheffield from 2000 to 2005 found that eight of these patients had presented to health professionals with symptoms of malaria but were not immediately referred to hospital or for a diagnostic test, suggesting that the diagnosis of malaria had not been considered. 6 A retrospective case review of 211 children admitted to hospital with malaria in east London found that 114 had initially presented to their doctor, but malaria was suspected at the first visit in only 32% of these, and diagnosis was delayed in 53%, by one to 14 days.
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Why does this matter?
If untreated, malaria can be rapidly fatal, particularly in non-immune patients. Delay in diagnosis is associated with an increased risk of severe malaria and death. 5 8 The overall case fatality rate from malaria in the United Kingdom is 0.73%, 4 but for cases with signs of severe malaria (box) this may reach 10-20%. 9 Severe complications and death may occur within 24-48 hours of onset of symptoms. 10 11 Early diagnosis and appropriate treatment are therefore crucial.
How is malaria diagnosed? Clinical
Question anyone presenting with a history of fever or flu-like symptoms about travel to malaria endemic countries within the past year. Investigate urgently those returning from a malaria endemic area, regardless of whether they have taken malaria prophylaxis. Intermittent fever may be a feature of malaria, so temperature may be normal at the time of examination. A case series of 482 patients in the United States found that half of adult patients were not febrile when they presented, although most had a history of fever. 12 Other common symptoms include vomiting, diarrhoea, headache, and myalgia. 5 12 Most patients with P falciparum present within six months of returning from abroad, although later presentations may occur. The box shows the features of severe disease. Definition of severe malaria 9 In patients with Plasmodium falciparum asexual parasitaemia and no other obvious cause of symptoms, severe malaria is defined by one or more of the following features:
Clinical features
Impaired consciousness or coma from which patients cannot be roused 
Investigations
It is preferable to refer all patients with suspected malaria to hospital immediately for further investigation because of the risk of rapid progression of falciparum malaria. However, if the patient is relatively well and it is possible to obtain results rapidly (the same day), it may be reasonable to investigate in a primary care setting. This calls for some clinical judgment. If the risk of malaria is low and the patient is not severely ill, outpatient testing with next day results may be acceptable, but the patient should then be advised to reconsult rapidly if there is any worsening of symptoms.
The clinician should request an urgent full blood count and "malaria thick and thin films" (both on the same EDTA sample). Although microscopy is the standard diagnostic method, low density infection may be missed, 13 particularly if microscopists are inexperienced or if patients have taken an antimalarial or an antibiotic with antimalarial activity. Therefore, if the first slide gives a negative result, films should be repeated after 12-24 hours, and again after another 24 hours. The likelihood of malaria is low if experienced microscopists find three consecutive negative blood film results. 14 In the United Kingdom some haematology laboratories may also be able to perform a rapid diagnostic test. These tests are based on detection of parasite antigens or enzymes; a recent Cochrane review found that the sensitivity and specificity of the most common rapid diagnostic tests were both 95%, compared with microscopy. 15 Rapid diagnostic tests are useful in increasing speed of diagnosis, even in non-endemic countries 16 and, if available, can be used as an adjunct to microscopy, although they cannot replace it. All positive malaria test results should be telephoned immediately to the requesting doctor and communicated by the doctor to the patient.
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Thrombocytopenia is common in acute malaria, and, if otherwise unexplained, may be an important clue even if the blood film has been reported as negative. A prospective study looking at returning travellers with fever found that leucocyte counts <10×10 9 /L, platelet counts <150×10 9 /L, and haemoglobin levels <120 g/L were all associated with an increased probability of malaria. Thrombocytopenia was the best predictor, with a positive likelihood ratio of 11.
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How is malaria managed?
Seek expert advice on treatment, particularly if there are signs of complications. In the primary care setting, if there are any signs of severe malaria, refer the patient to hospital as an emergency and treat any complications (for example, shock, hypoglycaemia, convulsions) while awaiting transfer.
Most patients with falciparum malaria need admission to hospital, although recent evidence has suggested that a small selected group with uncomplicated falciparum malaria can be treated safely as outpatients. 18 19 Those with uncomplicated non-falciparum infections can usually be managed as outpatients provided they are able to take oral drugs. Mixed infections can occur and P falciparum may be missed or misdiagnosed. Therefore it is sensible to have a low threshold for admission and to advise all those treated as outpatients to seek further medical attention urgently if they deteriorate. It is also advisable to review all patients with malaria 1-2 weeks after completion of treatment. 18 19 Because of the risk of increasing drug resistance, the World Health Organization now recommends that uncomplicated P falciparum malaria should be treated with artemisinin combination therapies. 9 Recent studies have proved that intravenous artesunate is more effective than quinine for the treatment of severe malaria, 20 21 but UK guidelines still recommend quinine because artesunate is unlicensed in the European Union.
14 These guidelines are, however, currently under review. Chloroquine is usually effective for non-falciparum malarias; however, chloroquine resistant P vivax is increasingly prevalent in some areas (for example, Indonesia, Peru, and Oceania). 9 In addition, patients with P vivax or P ovale infections should have their glucose 6 phosphate dehydrogenase (G6PD) status checked and, unless significantly G6PD deficient, should also be treated with an appropriate course of primaquine to reduce the likelihood of relapses. 22 UK guidelines for malaria treatment 14 and a useful management algorithm are available at www.hpa.org.uk/Topics/InfectiousDiseases/ InfectionsAZ/Malaria/Guidelines/mala20guidelinesTreatment/.
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